C1q was purified from human serum and quantified as described (12 (link)). Human serum was obtained from the Etablissement Français du Sang (EFS) Rhône-Alpes (agreement number 14-1940 regarding its use in research). C1q collagen stalks (CLR) and C1q globular heads (GR) were prepared according to Tacnet-Delorme et al. (13 (link)). The recombinant protease tetramer C1r2s2 was produced and purified according to Bally et al. (14 (link)). Full-length LRP1 (soluble LRP1) was produced and purified according to De Nardis et al. (15 (link)). Recombinant C1q and C1q mutant LysA59Ala/LysB61Ala/LysC58Ala were produced and purified as described in Bally et al. (16 (link)). For protein quantification, Mw and A1%, 1 cm were respectively for C1q (459,300; 6.8) (12 (link)), CLR (189,900; 2.1), GR (48,000; 9.3) (17 (link)), C1r2s2 (330,000; 13.5) (18 (link)). Oligonucleotides were from Eurogentec. Restriction and modification enzymes were from New England Biolabs.
Full-length LRP1 Myc DDK clone (RC218369) was purchased from Origene. The pET22B-RAP plasmid was kindly provided by Søren Moestrup, Aahrus University, Denmark. pcDNA3.1 mini IV HA-tag was cloned as previously indicated (19 (link)).
Free full text: Click here